![]() | |
Clinical data | |
---|---|
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider |
|
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.450 ![]() |
Chemical and physical data | |
Formula | C24H31N3OS |
Molar mass | 409.59 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class. [2] It was approved in 1967, and possibly discontinued in the 1980s.
Butaperazine can be synthesized starting from 2-butyrylphenothiazine (1). [3] It is prepared in a manner that is comparable to the method used in the synthesis of propiomazine and propiopromazine.[ clarification needed ] The phenothiazine is alkylated with 1-(γ-chloropropyl)-4-methylpiperazine (2), which is prepared in the conventional way by alkylating 1-methylpiperazine with 1-bromo-3-chloropropane.
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
H1 |
| ||||
---|---|---|---|---|---|
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||
Classes | |
---|---|
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |